<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03540290</url>
  </required_header>
  <id_info>
    <org_study_id>PER-ECL-2017-01</org_study_id>
    <nct_id>NCT03540290</nct_id>
  </id_info>
  <brief_title>Treatment of Peri-implant Mucositis by Means of Implant Decontamination and Modification of the Implant Supported-prosthesis</brief_title>
  <official_title>Treatment of Peri-implant Mucositis by Means of Implant Decontamination and Modification of the Implant Supported-prosthesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitat Internacional de Catalunya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitat Internacional de Catalunya</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To test the modification of the implant prosthesis, in order to facilitate access to biofilm
      control, in combination with decontamination of the implant surface by means of an ultrasonic
      device with a plastic tip and plastic curettes, in comparison with the decontamination of the
      implant surface by means of an ultrasonic device with a plastic tip and plastic curettes, and
      no modification of the implant prosthesis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 10, 2017</start_date>
  <completion_date type="Anticipated">June 20, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 12, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate modified sulcus Bleeding Index changes at 3 and 6 months, by the modification of the implant prosthesis in order to facilitate oral hygiene, hygiene instructions and surface decontamination</measure>
    <time_frame>1, 3 and 6 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Peri-implant Mucositis</condition>
  <arm_group>
    <arm_group_label>Mechanical instrumentation and oral hygiene instructions</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Modification of the implant supported prostheses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Modification of the implant supported prostheses in order to facilitate oral hygiene</intervention_name>
    <description>Peri-implant mucositis will be treated by individualized oral hygiene instructions and decontamination of the implant surface by ultrasonic device with a plastic tip and plastic curettes plus the modification of the implant prosthesis in order to facilitate oral hygiene access</description>
    <arm_group_label>Mechanical instrumentation and oral hygiene instructions</arm_group_label>
    <arm_group_label>Modification of the implant supported prostheses</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  (1) Presence of, at least, one titanium implant exhibiting peri-implant mucositis,
             defined as bleeding on gentle probing (0.15 N) in at least one peri-implant site.

             (2) No signs of loss of supporting bone after initial bone remodelling. In cases where
             baseline radiograph is available, it will be used for comparison, otherwise a maximum
             of 2 mm of crestal bone loss will be accepted (5).

             (3) Single tooth and bridgework restoration with an inappropriate prosthesis design or
             contour which difficult oral hygiene access (overcontoured prosthesis, prostheses
             presenting closed embrasures, an abrupt emergence profile or excessive buccal
             flanges).

             (4) Presence of &gt;1 mm of keratinized peri-implant mucosa.

             (5) A good level of oral hygiene, defined as an O'Leary et al. plaque index &lt;25% (16).

             (6) Absence of systemic diseases that could influence the outcome of the therapy (i.e.
             controlled diabetes, with HbA1c&lt;7, patients will be included).

             (7) Non-smoker or light smoking status in smokers (&lt;10 cigarettes/day).

        Exclusion Criteria:

          -  (1) Untreated periodontal conditions.

             (2) Pregnant or lactating women.

             (3) Patients who received systemic antibiotics in the last 3 months.

             (4) Patients who received treatment of PM in the past 3 months.

             (5) Patients receiving corticoids or medications known to have effect on gingival
             growth i.e. calcium channel antagonists, immunosuppressants or antiepileptic drugs.

        In those cases diagnosed with peri-implantitis, individualized treatment will be provided,
        apart from the present study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Beatriz de Tapia</last_name>
    <phone>0034 646486084</phone>
    <email>beatrizdetapia@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universitat Internacional de Catalunya</name>
      <address>
        <city>Barcelona</city>
        <state>Sant Cugat Del Vall√®s</state>
        <zip>08195</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beatriz de Tapia</last_name>
      <phone>0034646486084</phone>
      <email>beatrizdetapia@gmail.com</email>
    </contact>
    <contact_backup>
      <phone>0034646486084</phone>
      <email>beatrizdetapia@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>April 27, 2018</study_first_submitted>
  <study_first_submitted_qc>May 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2018</study_first_posted>
  <last_update_submitted>October 22, 2018</last_update_submitted>
  <last_update_submitted_qc>October 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitat Internacional de Catalunya</investigator_affiliation>
    <investigator_full_name>Beatriz de Tapia</investigator_full_name>
    <investigator_title>Clinical professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mucositis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The results obtained are expected to be published in both national and international journals. In addition, the results will be disseminated national and international scientific events.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

